<LEGAL_ROLE start="0" end="34" id="8050_2" >Petitioner Erica P. John Fund, Inc</LEGAL_ROLE>

<ORGANIZATION start="37" end="45" id="8050_3" >EPJ Fund</ORGANIZATION>

<LEGAL_ROLE start="60" end="69" id="8050_4" >plaintiff</LEGAL_ROLE>

<ORGANIZATION start="128" end="142" id="8050_5" >Halliburton Co</ORGANIZATION>

<PROFESSION start="159" plural="True" end="169" id="8050_6" >executives</PROFESSION>

<PERSON start="184" end="195" id="8050_7" >Halliburton</PERSON>

<ORGANIZATION start="198" end="206" id="8050_8" >EPJ Fund</ORGANIZATION>

<PERSON start="220" end="231" id="8050_9" >Halliburton</PERSON>

<NAME id="8050_10" start="341" all_names="SECURITIESEXCHANGEACT" local_name_id="1" end="364" >Securities Exchange Act</NAME>

<DATE start="368" end="372" id="8050_1" >1934</DATE>

<NAME id="8050_11" start="401" all_names="COMMISSIONRULE" local_name_id="2" end="416" >Commission Rule</NAME>

<ORGANIZATION start="424" end="432" id="8050_12" >EPJ Fund</ORGANIZATION>

<PERSON start="452" end="463" id="8050_13" >Halliburton</PERSON>

<ORGANIZATION start="590" end="598" id="8050_14" >EPJ Fund</ORGANIZATION>

<NAME id="8050_15" start="655" all_names="FEDERALRULE" local_name_id="3" end="667" >Federal Rule</NAME>

<ORGANIZATION start="671" end="709" id="8050_16" >Civil Procedure 23. The District Court</ORGANIZATION>

<NAME id="8050_17" start="768" all_names="RULE" local_name_id="4" end="772" >Rule</NAME>

<LEGAL_ROLE start="854" plural="True" end="864" id="8050_18" >plaintiffs</LEGAL_ROLE>

<LEGAL_ROLE start="907" end="916" id="8050_19" >defendant</LEGAL_ROLE>

<ORGANIZATION start="1027" end="1041" id="8050_20" >District Court</ORGANIZATION>

<ORGANIZATION start="1057" end="1065" id="8050_21" >EPJ Fund</ORGANIZATION>

<ORGANIZATION start="1110" end="1115" id="8050_22" >Court</ORGANIZATION>

<LEGAL_ROLE start="1205" plural="True" end="1215" id="8050_23" >plaintiffs</LEGAL_ROLE>

<NAME id="8050_24" start="1286" all_names="PP" local_name_id="5" end="1288" >Pp</NAME>

<NAME id="8050_33" start="1335" all_names="RULE" local_name_id="4" end="1339" >Rule</NAME>

<NAME id="8050_34" start="1852" all_names="RULE" local_name_id="4" end="1856" >Rule</NAME>

<LEGAL_ROLE start="1921" end="1930" id="8050_35" >defendant</LEGAL_ROLE>

<CITATION entry_type="case_X_vs_Y" id1="Dummy_File_360167" start="2142" alternative_keys="['u.s._563____']" line="3" party2_short="Siracusano" end="2181" citation_local_level_id="0" party1="Matrixx Initiatives, Inc." party2="Siracusano" id="8050_27" citation_global_level_id="360166.004" party1_short="Initiatives" >Matrixx Initiatives, Inc. v. Siracusano</CITATION>

<ORGANIZATION start="2142" party1_of="8050_27" end="2167" id="8050_29" >Matrixx Initiatives, Inc.</ORGANIZATION>

<ORGANIZATION start="2142" end="2166" id="8050_36" >Matrixx Initiatives, Inc</ORGANIZATION>

<NAME all_names="SIRACUSANO" id="8050_30" start="2171" party2_of="8050_27" local_name_id="6" end="2181" >Siracusano</NAME>

<CITATION entry_type="standard_key" line="3" id1="Dummy_File_360167" start="2183" lookup_key="u.s._563____" standard_reporter="U.S." end="2196" page_number="___" reporter="U. S." citation_local_level_id="1" citation_global_level_id="360166.003" id="8050_25" volume="563" no_current_file="True" >563 U. S. ___</CITATION>

<LEGAL_ROLE start="2335" end="2344" id="8050_37" >plaintiff</LEGAL_ROLE>

<ORGANIZATION start="2545" end="2550" id="8050_38" >Court</ORGANIZATION>

<CITATION entry_type="case_X_vs_Y" id1="Dummy_File_342840" start="2565" alternative_keys="['u.s._485_224']" line="3" party2_short="Levinson" end="2587" citation_local_level_id="2" party1="Basic Inc." party2="Levinson" id="8050_28" citation_global_level_id="342839.01" party1_short="Inc" >Basic Inc. v. Levinson</CITATION>

<ORGANIZATION start="2565" party1_of="8050_28" end="2575" id="8050_31" >Basic Inc.</ORGANIZATION>

<ORGANIZATION start="2565" end="2574" id="8050_39" >Basic Inc</ORGANIZATION>

<PERSON start="2579" party2_of="8050_28" end="2587" id="8050_32" >Levinson</PERSON>

<CITATION entry_type="standard_key" line="3" id1="Dummy_File_342840" start="2589" lookup_key="u.s._485_224" standard_reporter="U.S." end="2602" page_number="224" reporter="U. S." citation_local_level_id="3" citation_global_level_id="342839.003" id="8050_26" volume="485" no_current_file="True" >485 U. S. 224</CITATION>

<LEGAL_ROLE start="2745" plural="True" end="2755" id="8050_40" >plaintiffs</LEGAL_ROLE>

<ORGANIZATION start="2874" end="2879" id="8050_41" >Court</ORGANIZATION>

<LEGAL_ROLE start="2936" plural="True" end="2946" id="8050_42" >plaintiffs</LEGAL_ROLE>

<ORGANIZATION start="3270" end="3275" id="8050_43" >Court</ORGANIZATION>

<ORGANIZATION start="3428" end="3433" id="8050_44" >Court</ORGANIZATION>

<NAME id="8050_45" start="3514" all_names="PP" local_name_id="5" end="3516" >Pp</NAME>

<LEGAL_ROLE start="3567" plural="True" end="3577" id="8050_52" >plaintiffs</LEGAL_ROLE>

<ORGANIZATION start="3684" end="3689" id="8050_53" >Court</ORGANIZATION>

<ORGANIZATION start="3702" end="3710" id="8050_54" >EPJ Fund</ORGANIZATION>

<ORGANIZATION start="3862" end="3867" id="8050_55" >Court</ORGANIZATION>

<ORGANIZATION start="4131" end="4136" id="8050_60" >Court</ORGANIZATION>

<NAME id="8050_61" start="4190" all_names="RULE" local_name_id="4" end="4194" >Rule</NAME>

<CITATION entry_type="case_X_vs_Y" id1="Dummy_File_345361" start="4256" alternative_keys="['u.s._544_336']" line="5" party2_short="Broudo" end="4292" citation_local_level_id="4" party1="Dura Pharmaceuticals, Inc." party2="Broudo" id="8050_57" citation_global_level_id="345360.012" party1_short="Pharmaceuticals" >Dura Pharmaceuticals, Inc. v. Broudo</CITATION>

<ORGANIZATION start="4256" party1_of="8050_57" end="4282" id="8050_58" >Dura Pharmaceuticals, Inc.</ORGANIZATION>

<ORGANIZATION start="4256" end="4281" id="8050_62" >Dura Pharmaceuticals, Inc</ORGANIZATION>

<NAME all_names="BROUDO" id="8050_59" start="4286" party2_of="8050_57" local_name_id="7" end="4292" >Broudo</NAME>

<CITATION entry_type="standard_key" line="5" id1="Dummy_File_345361" start="4294" lookup_key="u.s._544_336" standard_reporter="U.S." end="4316" page_number="336" reporter="U. S." citation_local_level_id="5" paragraph_number="341-342" id="8050_56" volume="544" no_current_file="True" citation_global_level_id="345360.003" >544 U. S. 336, 341-342</CITATION>

<LEGAL_ROLE start="4379" end="4388" id="8050_63" >plaintiff</LEGAL_ROLE>

<ORGANIZATION start="4428" end="4433" id="8050_64" >Court</ORGANIZATION>

<LEGAL_ROLE start="4571" end="4580" id="8050_65" >plaintiff</LEGAL_ROLE>

<ORGANIZATION start="4815" end="4820" id="8050_66" >Court</ORGANIZATION>

<NAME id="8050_67" start="5021" all_names="PP" local_name_id="5" end="5023" >Pp</NAME>

<PERSON start="5035" end="5046" id="8050_71" >Halliburton</PERSON>

<LEGAL_ROLE start="5078" plural="True" end="5088" id="8050_72" >plaintiffs</LEGAL_ROLE>

<PERSON start="5188" end="5199" id="8050_73" >Halliburton</PERSON>

<ORGANIZATION start="5262" end="5267" id="8050_74" >Court</ORGANIZATION>

<ORGANIZATION start="5304" end="5312" id="8050_75" >EPJ Fund</ORGANIZATION>

<ORGANIZATION start="5346" end="5351" id="8050_76" >Court</ORGANIZATION>

<PERSON start="5385" end="5396" id="8050_77" >Halliburton</PERSON>

<PERSON start="5489" end="5500" id="8050_78" >Halliburton</PERSON>

<ORGANIZATION start="5522" end="5530" id="8050_79" >EPJ Fund</ORGANIZATION>

<ORGANIZATION start="5662" end="5667" id="8050_80" >Court</ORGANIZATION>

<ORGANIZATION start="5684" end="5692" id="8050_81" >EPJ Fund</ORGANIZATION>

<ORGANIZATION start="5717" end="5722" id="8050_82" >Court</ORGANIZATION>

<PERSON start="5846" end="5857" id="8050_83" >Halliburton</PERSON>

<ORGANIZATION start="5869" end="5874" id="8050_84" >Court</ORGANIZATION>

<ORGANIZATION start="5937" end="5942" id="8050_85" >Court</ORGANIZATION>

<ORGANIZATION start="5953" end="5958" id="8050_86" >Court</ORGANIZATION>

<NAME id="8050_87" start="6038" all_names="PP" local_name_id="5" end="6040" >Pp</NAME>

<CITATION entry_type="standard_key" line="7" id1="Dummy_File_360391" start="6047" lookup_key="f.3d_597_330" standard_reporter="F.3D" end="6060" page_number="330" reporter="F. 3d" citation_local_level_id="6" citation_global_level_id="360390.001" id="8050_88" volume="597" no_current_file="True" >597 F. 3d 330</CITATION>

<PERSON start="6085" end="6092" id="8050_89" >Roberts</PERSON>

<ORGANIZATION start="6139" end="6144" id="8050_90" >Court</ORGANIZATION>

<ORGANIZATION start="6146" end="6169" id="8050_95" >ERICA P. JOHN FUND, INC</ORGANIZATION>

<CITATION entry_type="party_key" line="9" id1="Dummy_File_360392" start="6176" lookup_key="archdiocesehalliburton#1" party2_short="HALLIBURTON" end="6258" citation_local_level_id="7" party1="ARCHDIOCESE OF MILWAUKEE SUPPORTING FUND, INC.," party2="HALLIBURTON CO. et al" id="8050_91" no_current_file="True" party1_role="petitioner" citation_global_level_id="360391.001" party1_short="ARCHDIOCESE" >ARCHDIOCESE OF MILWAUKEE SUPPORTING FUND, INC.,PETITIONER v. HALLIBURTON CO. et al</CITATION>

<NAME id="8050_92" start="6176" all_names="ARCHDIOCESEOFMILWAUKEESUPPORTINGFUNDINC" local_name_id="8" end="6223" party1_of="8050_91" >ARCHDIOCESE OF MILWAUKEE SUPPORTING FUND, INC.,</NAME>

<ORGANIZATION start="6176" end="6221" id="8050_96" >ARCHDIOCESE OF MILWAUKEE SUPPORTING FUND, INC</ORGANIZATION>

<LEGAL_ROLE start="6223" end="6233" id="8050_94" >PETITIONER</LEGAL_ROLE>

<GPE start="6237" party2_of="8050_91" end="6258" id="8050_93" >HALLIBURTON CO. et al</GPE>

<ORGANIZATION start="6237" end="6251" id="8050_97" >HALLIBURTON CO</ORGANIZATION>

<DATE start="6343" end="6355" id="8050_100" >June 6, 2011</DATE>

<PROFESSION start="6358" document_level_name_id="9" party="ROBERTS" end="6371" id="8050_101" >Chief Justice</PROFESSION>

<PERSON start="6372" end="6379" id="8050_102" >Roberts</PERSON>

<ORGANIZATION start="6409" end="6414" id="8050_103" >Court</ORGANIZATION>

<LEGAL_ROLE start="6516" end="6525" id="8050_105" >defendant</LEGAL_ROLE>

<LEGAL_ROLE start="6708" plural="True" end="6718" id="8050_106" >plaintiffs</LEGAL_ROLE>

<LEGAL_ROLE start="6821" end="6855" id="8050_109" >Petitioner Erica P. John Fund, Inc</LEGAL_ROLE>

<ORGANIZATION start="6858" end="6866" id="8050_110" >EPJ Fund</ORGANIZATION>

<LEGAL_ROLE start="6881" end="6890" id="8050_111" >plaintiff</LEGAL_ROLE>

<ORGANIZATION start="6949" end="6963" id="8050_112" >Halliburton Co</ORGANIZATION>

<PROFESSION start="6980" plural="True" end="6990" id="8050_113" >executives</PROFESSION>

<PERSON start="7005" end="7016" id="8050_114" >Halliburton</PERSON>

<PERSON start="7081" end="7092" id="8050_115" >Halliburton</PERSON>

<DATE start="7114" end="7126" id="8050_107" >June 3, 1999</DATE>

<DATE start="7132" end="7148" id="8050_108" >December 7, 2001</DATE>

<ORGANIZATION start="7151" end="7159" id="8050_118" >EPJ Fund</ORGANIZATION>

<PERSON start="7173" end="7184" id="8050_119" >Halliburton</PERSON>

<NAME id="8050_120" start="7284" all_names="SECURITIESEXCHANGEACT" local_name_id="1" end="7307" >Securities Exchange Act</NAME>

<DATE start="7311" end="7315" id="8050_116" >1934</DATE>

<NAME id="8050_121" start="7344" all_names="COMMISSIONRULE" local_name_id="2" end="7359" >Commission Rule</NAME>

<NAME id="8050_122" start="7374" all_names="STAT" local_name_id="9" end="7378" >Stat</NAME>

<DATE start="7425" end="7429" id="8050_117" >2010</DATE>

<PERSON start="7459" end="7470" id="8050_123" >Halliburton</PERSON>

<ORGANIZATION start="7696" end="7704" id="8050_124" >EPJ Fund</ORGANIZATION>

<PERSON start="7719" end="7730" id="8050_125" >Halliburton</PERSON>

<ORGANIZATION start="7895" end="7903" id="8050_126" >EPJ Fund</ORGANIZATION>

<NAME id="8050_127" start="7960" all_names="FEDERALRULE" local_name_id="3" end="7972" >Federal Rule</NAME>

<NAME id="8050_128" start="7976" all_names="CIVILPROCEDURE23THE" local_name_id="10" end="7999" >Civil Procedure 23. The</NAME>

<ORGANIZATION start="8024" end="8038" id="8050_129" >District Court</ORGANIZATION>

<ORGANIZATION start="8050" end="8058" id="8050_130" >EPJ Fund</ORGANIZATION>

<PROFESSION start="8073" end="8080" id="8050_131" >general</PROFESSION>

<NAME id="8050_132" start="8123" all_names="RULE" local_name_id="4" end="8127" >Rule</NAME>

<PERSON start="8370" end="8373" id="8050_133" >App</PERSON>

<NAME id="8050_134" start="8387" all_names="CERT" local_name_id="11" end="8391" >Cert</NAME>

<ORGANIZATION start="8402" end="8416" id="8050_145" >District Court</ORGANIZATION>

<NAME id="8050_146" start="8482" all_names="RULE" local_name_id="4" end="8486" >Rule</NAME>

<LEGAL_ROLE start="8562" plural="True" end="8572" id="8050_147" >plaintiffs</LEGAL_ROLE>

<CITATION entry_type="party_key" line="18" id1="Dummy_File_360393" start="8668" lookup_key="invstelecom#1" party2_short="Telecom" end="8716" citation_local_level_id="8" party1="Oscar Private Equity Invs." party2="Allegiance Telecom" id="8050_137" no_current_file="True" citation_global_level_id="360392.001" party1_short="Invs" >Oscar Private Equity Invs. v. Allegiance Telecom</CITATION>

<NAME id="8050_139" start="8668" all_names="OSCARPRIVATEEQUITYINVS" local_name_id="12" end="8694" party1_of="8050_137" >Oscar Private Equity Invs.</NAME>

<NAME all_names="ALLEGIANCETELECOM" id="8050_140" start="8698" party2_of="8050_137" local_name_id="13" end="8716" >Allegiance Telecom</NAME>

<ORGANIZATION start="8718" end="8721" id="8050_148" >Inc</ORGANIZATION>

<CITATION entry_type="standard_key" line="18" id1="Dummy_File_360394" start="8724" lookup_key="f.3d_487_261" standard_reporter="F.3D" end="8742" page_number="261" reporter="F. 3d" citation_local_level_id="9" paragraph_number="269" id="8050_135" volume="487" no_current_file="True" citation_global_level_id="360393.001" >487 F. 3d 261, 269</CITATION>

<GPE start="8744" end="8746" id="8050_149" >CA</GPE>

<DATE start="8748" end="8752" id="8050_143" >2007</DATE>

<ORGANIZATION start="8763" end="8777" id="8050_150" >District Court</ORGANIZATION>

<PERSON start="8921" end="8924" id="8050_151" >App</PERSON>

<NAME id="8050_152" start="8938" all_names="CERT" local_name_id="11" end="8942" >Cert</NAME>

<CITATION entry_type="case_X_vs_Y" id1="Dummy_File_345361" start="8966" alternative_keys="['u.s._544_336']" line="18" party2_short="Broudo" end="9002" citation_local_level_id="10" party1="Dura Pharmaceuticals, Inc." party2="Broudo" id="8050_138" citation_global_level_id="345360.013" party1_short="Pharmaceuticals" >Dura Pharmaceuticals, Inc. v. Broudo</CITATION>

<ORGANIZATION start="8966" party1_of="8050_138" end="8992" id="8050_141" >Dura Pharmaceuticals, Inc.</ORGANIZATION>

<ORGANIZATION start="8966" end="8991" id="8050_153" >Dura Pharmaceuticals, Inc</ORGANIZATION>

<NAME all_names="BROUDO" id="8050_142" start="8996" party2_of="8050_138" local_name_id="7" end="9002" >Broudo</NAME>

<CITATION entry_type="standard_key" page_number="336" start="9004" line="18" standard_reporter="U.S." end="9029" year="2005" lookup_key="u.s._544_336" reporter="U. S." citation_local_level_id="11" paragraph_number="342" id="8050_136" id1="Dummy_File_345361" volume="544" no_current_file="True" citation_global_level_id="345360.003" >544 U. S. 336, 342 (2005)</CITATION>

<DATE start="9024" citation_local_level_id="11" citation_global_level_id="345360.003" end="9028" id="8050_144" >2005</DATE>

<ORGANIZATION start="9111" end="9125" id="8050_154" >District Court</ORGANIZATION>

<ORGANIZATION start="9193" end="9201" id="8050_155" >EPJ Fund</ORGANIZATION>

<PERSON start="9278" end="9281" id="8050_156" >App</PERSON>

<NAME id="8050_157" start="9295" all_names="CERT" local_name_id="11" end="9299" >Cert</NAME>

<ORGANIZATION start="9420" end="9424" id="8050_158" >Fund</ORGANIZATION>

<ORGANIZATION start="9461" end="9466" id="8050_167" >Court</ORGANIZATION>

<CITATION entry_type="standard_key" line="19" id1="Dummy_File_360391" start="9526" lookup_key="f.3d_597_330" standard_reporter="F.3D" end="9539" page_number="330" reporter="F. 3d" citation_local_level_id="12" citation_global_level_id="360390.001" id="8050_165" volume="597" no_current_file="True" >597 F. 3d 330</CITATION>

<GPE start="9541" end="9543" id="8050_168" >CA</GPE>

<DATE start="9545" end="9549" id="8050_166" >2010</DATE>

<ORGANIZATION start="9629" end="9637" id="8050_169" >EPJ Fund</ORGANIZATION>

<ORGANIZATION start="9824" end="9838" id="8050_170" >District Court</ORGANIZATION>

<ORGANIZATION start="9844" end="9849" id="8050_171" >Court</ORGANIZATION>

<ORGANIZATION start="9876" end="9884" id="8050_172" >EPJ Fund</ORGANIZATION>

<ORGANIZATION start="10013" end="10017" id="8050_189" >Fund</ORGANIZATION>

<CITATION entry_type="standard_key" line="20" page_number="___" start="10045" lookup_key="u.s._562____" standard_reporter="U.S." end="10065" year="2011" reporter="U. S." citation_local_level_id="13" citation_global_level_id="358912.001" id="8050_175" id1="Dummy_File_358913" volume="562" no_current_file="True" >562 U. S. ___ (2011)</CITATION>

<DATE start="10060" citation_local_level_id="13" citation_global_level_id="358912.001" end="10064" id="8050_183" >2011</DATE>

<LEGAL_ROLE start="10139" plural="True" end="10149" id="8050_190" >plaintiffs</LEGAL_ROLE>

<CITATION entry_type="standard_key" line="20" id1="Dummy_File_360395" start="10224" lookup_key="f.3d_597_334" standard_reporter="F.3D" end="10241" page_number="334" reporter="F. 3d" citation_local_level_id="14" citation_global_level_id="360394.001" id="8050_176" volume="597" no_current_file="True" >597 F. 3d, at 334</CITATION>

<CITATION entry_type="case_key" line="20" id1="Dummy_File_360396" start="10261" alternative_keys="['f.3d_544_474']" lookup_key="inresalomonanalystmetromedialitigation#1" standard_reporter="F.3D" end="10304" page_number="474" volume="544" citation_local_level_id="15" citation_global_level_id="360395.003" name="In re Salomon Analyst Metromedia Litigation" id="8050_188" no_current_file="True" >In re Salomon Analyst Metromedia Litigation</CITATION>

<CITATION entry_type="standard_key" line="20" id1="Dummy_File_360396" start="10306" alternative_keys="['inresalomonanalystmetromedialitigation#1']" lookup_key="f.3d_544_474" standard_reporter="F.3D" end="10324" page_number="474" reporter="F. 3d" citation_local_level_id="16" paragraph_number="483" name="In re Salomon Analyst Metromedia Litigation" id="8050_177" volume="544" no_current_file="True" citation_global_level_id="360395.003" >544 F. 3d 474, 483</CITATION>

<GPE start="10326" end="10328" id="8050_191" >CA</GPE>

<DATE start="10330" end="10334" id="8050_184" >2008</DATE>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<CITATION entry_type="party_key" line="20" id1="Dummy_File_360397" start="10416" alternative_keys="['f.3d_618_679']" lookup_key="schleicherwendt#1" party2_short="Wendt" end="10435" standard_reporter="F.3D" citation_local_level_id="17" volume="618" party1="Schleicher" party2="Wendt" id="8050_180" no_current_file="True" page_number="679" citation_global_level_id="360396.003" party1_short="Schleicher" >Schleicher v. Wendt</CITATION>

<PERSON start="10416" party1_of="8050_180" end="10426" id="8050_181" >Schleicher</PERSON>

<PERSON start="10430" party2_of="8050_180" end="10435" id="8050_182" >Wendt</PERSON>

<CITATION entry_type="standard_key" line="20" id1="Dummy_File_360397" start="10437" alternative_keys="['schleicherwendt#1']" lookup_key="f.3d_618_679" standard_reporter="F.3D" end="10455" page_number="679" reporter="F. 3d" citation_local_level_id="18" paragraph_number="687" id="8050_178" volume="618" no_current_file="True" citation_global_level_id="360396.003" >618 F. 3d 679, 687</CITATION>

<GPE start="10457" end="10459" id="8050_192" >CA</GPE>

<DATE start="10461" end="10465" id="8050_185" >2010</DATE>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="10481" end="10512" id="8050_193" >DVI, Inc. Securities Litigation</ORGANIZATION>

<DOCKET start="10518" entry_type="docket" line="20" end="10525" id="8050_179" >08-8033</DOCKET>

<DATE start="10532" end="10536" id="8050_186" >2011</DATE>

<GPE start="10553" end="10555" id="8050_194" >CA</GPE>

<DATE start="10558" end="10571" id="8050_187" >Mar. 29, 2011</DATE>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="10623" end="10631" id="8050_200" >EPJ Fund</ORGANIZATION>

<ORGANIZATION start="10650" end="10655" id="8050_201" >Court</ORGANIZATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="10791" end="10799" id="8050_212" >EPJ Fund</ORGANIZATION>

<NAME id="8050_213" start="10831" all_names="RULE" local_name_id="4" end="10835" >Rule</NAME>

<NAME id="8050_214" start="10885" all_names="RULE" local_name_id="4" end="10889" >Rule</NAME>

<NAME id="8050_215" start="11160" all_names="RULECIV" local_name_id="14" end="11168" >Rule Civ</NAME>

<NAME id="8050_216" start="11170" all_names="PROC" local_name_id="15" end="11174" >Proc</NAME>

<NAME id="8050_217" start="11424" all_names="RULE" local_name_id="4" end="11428" >Rule</NAME>

<LEGAL_ROLE start="11495" end="11504" id="8050_218" >defendant</LEGAL_ROLE>

<CITATION entry_type="case_X_vs_Y" id1="Dummy_File_360167" start="11718" alternative_keys="['u.s._563____']" line="24" party2_short="Siracusano" end="11757" citation_local_level_id="19" party1="Matrixx Initiatives, Inc." party2="Siracusano" id="8050_204" citation_global_level_id="360166.005" party1_short="Initiatives" >Matrixx Initiatives, Inc. v. Siracusano</CITATION>

<ORGANIZATION start="11718" party1_of="8050_204" end="11743" id="8050_206" >Matrixx Initiatives, Inc.</ORGANIZATION>

<ORGANIZATION start="11718" end="11742" id="8050_219" >Matrixx Initiatives, Inc</ORGANIZATION>

<NAME all_names="SIRACUSANO" id="8050_207" start="11747" party2_of="8050_204" local_name_id="6" end="11757" >Siracusano</NAME>

<CITATION entry_type="standard_key" line="24" id1="Dummy_File_360167" start="11759" lookup_key="u.s._563____" standard_reporter="U.S." end="11772" page_number="___" reporter="U. S." citation_local_level_id="20" citation_global_level_id="360166.003" id="8050_202" volume="563" no_current_file="True" >563 U. S. ___</CITATION>

<DATE start="11779" end="11783" id="8050_210" >2011</DATE>

<CITATION entry_type="case_X_vs_Y" id1="Dummy_File_358175" start="11811" alternative_keys="['u.s._552_148']" line="24" party2_short="Atlanta" end="11873" citation_local_level_id="21" party1="Stoneridge Investment Partners, LLC" party2="Scientific-Atlanta, Inc" id="8050_205" citation_global_level_id="358174.007" party1_short="LLC" >Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc</CITATION>

<NAME id="8050_208" start="11811" all_names="STONERIDGEINVESTMENTPARTNERSLLC" local_name_id="16" end="11846" party1_of="8050_205" >Stoneridge Investment Partners, LLC</NAME>

<NAME id="8050_220" start="11811" all_names="STONERIDGEINVESTMENTPARTNERS" local_name_id="17" end="11841" >Stoneridge Investment Partners</NAME>

<ORGANIZATION start="11850" party2_of="8050_205" end="11873" id="8050_209" >Scientific-Atlanta, Inc</ORGANIZATION>

<CITATION entry_type="standard_key" page_number="148" start="11876" line="24" standard_reporter="U.S." end="11901" year="2008" lookup_key="u.s._552_148" reporter="U. S." citation_local_level_id="22" paragraph_number="157" id="8050_203" id1="Dummy_File_358175" volume="552" no_current_file="True" citation_global_level_id="358174.003" >552 U. S. 148, 157 (2008)</CITATION>

<DATE start="11896" citation_local_level_id="22" citation_global_level_id="358174.003" end="11900" id="8050_211" >2008</DATE>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="12059" end="12067" id="8050_228" >EPJ Fund</ORGANIZATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<LEGAL_ROLE start="12230" end="12239" id="8050_234" >plaintiff</LEGAL_ROLE>

<LEGAL_ROLE start="12249" end="12258" id="8050_235" >defendant</LEGAL_ROLE>

<NAME id="8050_236" start="12340" all_names="STONERIDGE" local_name_id="18" end="12350" >Stoneridge</NAME>

<LEGAL_ROLE start="12454" end="12463" id="8050_237" >defendant</LEGAL_ROLE>

<LEGAL_ROLE start="12490" end="12499" id="8050_238" >plaintiff</LEGAL_ROLE>

<CITATION entry_type="case_X_vs_Y" id1="Dummy_File_342840" start="12511" alternative_keys="['u.s._485_224']" line="26" party2_short="Levinson" end="12533" citation_local_level_id="23" party1="Basic Inc." party2="Levinson" id="8050_230" citation_global_level_id="342839.011" party1_short="Inc" >Basic Inc. v. Levinson</CITATION>

<ORGANIZATION start="12511" party1_of="8050_230" end="12521" id="8050_231" >Basic Inc.</ORGANIZATION>

<ORGANIZATION start="12511" end="12520" id="8050_239" >Basic Inc</ORGANIZATION>

<PERSON start="12525" party2_of="8050_230" end="12533" id="8050_232" >Levinson</PERSON>

<CITATION entry_type="standard_key" page_number="224" start="12535" line="26" standard_reporter="U.S." end="12560" year="1988" lookup_key="u.s._485_224" reporter="U. S." citation_local_level_id="24" paragraph_number="243" id="8050_229" id1="Dummy_File_342840" volume="485" no_current_file="True" citation_global_level_id="342839.003" >485 U. S. 224, 243 (1988)</CITATION>

<DATE start="12555" citation_local_level_id="24" citation_global_level_id="342839.003" end="12559" id="8050_233" >1988</DATE>

<LEGAL_ROLE start="12602" end="12611" id="8050_240" >plaintiff</LEGAL_ROLE>

<LEGAL_ROLE start="12831" end="12840" id="8050_241" >plaintiff</LEGAL_ROLE>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<NAME id="8050_246" start="13161" all_names="RULE" local_name_id="4" end="13165" >Rule</NAME>

<LEGAL_ROLE start="13172" end="13181" id="8050_247" >plaintiff</LEGAL_ROLE>

<LEGAL_ROLE start="13385" plural="True" end="13395" id="8050_248" >plaintiffs</LEGAL_ROLE>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="13515" end="13520" id="8050_250" >Court</ORGANIZATION>

<LEGAL_ROLE start="13587" plural="True" end="13597" id="8050_251" >plaintiffs</LEGAL_ROLE>

<ORGANIZATION start="14015" end="14020" id="8050_252" >Court</ORGANIZATION>

<NAME id="8050_253" start="14208" all_names="STONERIDGE" local_name_id="18" end="14218" >Stoneridge</NAME>

<NAME id="8050_254" start="14235" all_names="DURAPHARMACEUTICALS" local_name_id="19" end="14255" >Dura Pharmaceuticals</NAME>

<CITATION entry_type="standard_key" line="28" id1="Dummy_File_349203" start="14257" lookup_key="u.s._544_341" standard_reporter="U.S." end="14274" page_number="341" reporter="U. S." citation_local_level_id="25" citation_global_level_id="349202.001" id="8050_249" volume="544" no_current_file="True" >544 U. S., at 341</CITATION>

<ORGANIZATION start="14284" end="14289" id="8050_255" >Court</ORGANIZATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<LEGAL_ROLE start="14457" plural="True" end="14467" id="8050_257" >plaintiffs</LEGAL_ROLE>

<LEGAL_ROLE start="14596" plural="True" end="14606" id="8050_258" >plaintiffs</LEGAL_ROLE>

<CITATION entry_type="standard_key" line="30" id1="Dummy_File_360398" start="14920" lookup_key="u.s._485_248" standard_reporter="U.S." end="14937" page_number="248" reporter="U. S." citation_local_level_id="26" citation_global_level_id="360397.001" id="8050_256" volume="485" no_current_file="True" >485 U. S., at 248</CITATION>

<NAME id="8050_259" start="14972" all_names="STONERIDGE" local_name_id="18" end="14982" >Stoneridge</NAME>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="15017" end="15022" id="8050_261" >Court</ORGANIZATION>

<ORGANIZATION start="15035" end="15043" id="8050_262" >EPJ Fund</ORGANIZATION>

<CITATION entry_type="standard_key" line="31" id1="Dummy_File_360399" start="15158" lookup_key="f.3d_597_335" standard_reporter="F.3D" end="15175" page_number="335" reporter="F. 3d" citation_local_level_id="27" citation_global_level_id="360398.001" id="8050_260" volume="597" no_current_file="True" >597 F. 3d, at 335</CITATION>

<ORGANIZATION start="15223" end="15231" id="8050_263" >EPJ Fund</ORGANIZATION>

<ORGANIZATION start="15450" end="15458" id="8050_264" >EPJ Fund</ORGANIZATION>

<PERSON start="15495" end="15506" id="8050_265" >Halliburton</PERSON>

<NAME id="8050_266" start="15799" all_names="DURAPHARMACEUTICALS" local_name_id="19" end="15819" >Dura Pharmaceuticals</NAME>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="15876" end="15881" id="8050_267" >Court</ORGANIZATION>

<PERSON start="16167" end="16171" id="8050_268" >Loss</PERSON>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<NAME id="8050_270" start="16385" all_names="RULE" local_name_id="4" end="16389" >Rule</NAME>

<NAME id="8050_271" start="16451" all_names="DURAPHARMACEUTICALS" local_name_id="19" end="16471" >Dura Pharmaceuticals</NAME>

<LEGAL_ROLE start="16587" end="16596" id="8050_272" >plaintiff</LEGAL_ROLE>

<NAME id="8050_273" start="16737" all_names="DURAPHARMACEUTICALS" local_name_id="19" end="16757" >Dura Pharmaceuticals</NAME>

<LEGAL_ROLE start="16857" end="16866" id="8050_274" >defendant</LEGAL_ROLE>

<CITATION entry_type="standard_key" line="33" id1="Dummy_File_360400" start="17010" lookup_key="u.s._485_247" standard_reporter="U.S." end="17027" page_number="247" reporter="U. S." citation_local_level_id="28" citation_global_level_id="360399.001" id="8050_269" volume="485" no_current_file="True" >485 U. S., at 247</CITATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<PERSON start="17030" end="17034" id="8050_276" >Loss</PERSON>

<LEGAL_ROLE start="17070" end="17079" id="8050_277" >plaintiff</LEGAL_ROLE>

<NAME id="8050_278" start="17221" all_names="DURAPHARMACEUTICALS" local_name_id="19" end="17241" >Dura Pharmaceuticals</NAME>

<CITATION entry_type="standard_key" line="34" id1="Dummy_File_360401" start="17435" lookup_key="u.s._544_342" standard_reporter="U.S." end="17452" page_number="342" reporter="U. S." citation_local_level_id="29" citation_global_level_id="360400.001" id="8050_275" volume="544" no_current_file="True" >544 U. S., at 342</CITATION>

<LEGAL_ROLE start="17826" end="17835" id="8050_279" >plaintiff</LEGAL_ROLE>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="18071" end="18076" id="8050_280" >Court</ORGANIZATION>

<LEGAL_ROLE start="18151" end="18160" id="8050_281" >plaintiff</LEGAL_ROLE>

<PERSON start="18691" end="18695" id="8050_282" >Loss</PERSON>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="18839" end="18844" id="8050_283" >Court</ORGANIZATION>

<ORGANIZATION start="18875" end="18883" id="8050_284" >EPJ Fund</ORGANIZATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<PERSON start="18959" end="18970" id="8050_285" >Halliburton</PERSON>

<LEGAL_ROLE start="19002" plural="True" end="19012" id="8050_286" >plaintiffs</LEGAL_ROLE>

<NAME id="8050_287" start="19157" all_names="TR" local_name_id="20" end="19159" >Tr</NAME>

<NAME id="8050_288" start="19164" all_names="ORALARG" local_name_id="21" end="19172" >Oral Arg</NAME>

<PERSON start="19181" end="19192" id="8050_289" >Halliburton</PERSON>

<ORGANIZATION start="19255" end="19260" id="8050_290" >Court</ORGANIZATION>

<LEGAL_ROLE start="19297" plural="True" end="19307" id="8050_291" >plaintiffs</LEGAL_ROLE>

<ORGANIZATION start="19410" end="19415" id="8050_292" >Court</ORGANIZATION>

<PERSON start="19428" end="19432" id="8050_293" >Dura</PERSON>

<PERSON start="19449" end="19460" id="8050_294" >Halliburton</PERSON>

<LEGAL_ROLE start="19538" plural="True" end="19549" id="8050_295" >Respondents</LEGAL_ROLE>

<NAME id="8050_296" start="19554" all_names="THE" local_name_id="22" end="19557" >The</NAME>

<PERSON start="19588" end="19599" id="8050_297" >Halliburton</PERSON>

<ORGANIZATION start="19621" end="19629" id="8050_298" >EPJ Fund</ORGANIZATION>

<NAME id="8050_299" start="19806" all_names="TR" local_name_id="20" end="19808" >Tr</NAME>

<NAME id="8050_300" start="19813" all_names="ORALARG" local_name_id="21" end="19821" >Oral Arg</NAME>

<ORGANIZATION start="19844" end="19849" id="8050_301" >Court</ORGANIZATION>

<ORGANIZATION start="19901" end="19909" id="8050_302" >EPJ Fund</ORGANIZATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<PERSON start="20073" end="20084" id="8050_303" >Halliburton</PERSON>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<PERSON start="20368" end="20379" id="8050_305" >Halliburton</PERSON>

<ORGANIZATION start="20412" end="20417" id="8050_306" >Court</ORGANIZATION>

<CITATION entry_type="standard_key" line="40" id1="Dummy_File_360402" start="20658" lookup_key="f.3d_597_336" standard_reporter="F.3D" end="20675" page_number="336" reporter="F. 3d" citation_local_level_id="30" citation_global_level_id="360401.001" id="8050_304" volume="597" no_current_file="True" >597 F. 3d, at 336</CITATION>

<ORGANIZATION start="20705" end="20710" id="8050_307" >Court</ORGANIZATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<PERSON start="20959" end="20970" id="8050_309" >Halliburton</PERSON>

<ORGANIZATION start="20982" end="20987" id="8050_310" >Court</ORGANIZATION>

<ORGANIZATION start="21048" end="21056" id="8050_311" >EPJ Fund</ORGANIZATION>

<CITATION entry_type="standard_key" line="41" id1="Dummy_File_360395" start="21221" lookup_key="f.3d_597_334" standard_reporter="F.3D" end="21238" page_number="334" reporter="F. 3d" citation_local_level_id="31" citation_global_level_id="360394.001" id="8050_308" volume="597" no_current_file="True" >597 F. 3d, at 334</CITATION>

<LEGAL_ROLE start="21269" plural="True" end="21279" id="8050_312" >plaintiffs</LEGAL_ROLE>

<ORGANIZATION start="21414" end="21419" id="8050_313" >Court</ORGANIZATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="21530" end="21535" id="8050_314" >Court</ORGANIZATION>

<ORGANIZATION start="21566" end="21574" id="8050_315" >EPJ Fund</ORGANIZATION>

<PERSON start="21759" end="21770" id="8050_316" >Halliburton</PERSON>

<ORGANIZATION start="21887" end="21892" id="8050_317" >Court</ORGANIZATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<ORGANIZATION start="21936" end="21941" id="8050_318" >Court</ORGANIZATION>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<COMMENT start="10337" entry_type="comment" line="20" end="10413" id="8050_173" >not requiring investors to prove loss causation at class certification stage</COMMENT>

<COMMENT start="10468" entry_type="comment" line="20" end="10472" id="8050_174" >same</COMMENT>

<NAME id="8050_319" start="22062" all_names="FOOTNOTESFOOTNOTE**HALLIBURTON" local_name_id="23" end="22094" >FOOTNOTESFootnote ** Halliburton</NAME>

<ORGANIZATION start="22153" end="22158" id="8050_320" >Court</ORGANIZATION>

<ORGANIZATION start="22212" end="22217" id="8050_321" >Court</ORGANIZATION>

<ORGANIZATION start="22268" end="22276" id="8050_322" >EPJ Fund</ORGANIZATION>

<NAME id="8050_323" start="22282" all_names="TR" local_name_id="20" end="22284" >Tr</NAME>

<NAME id="8050_324" start="22289" all_names="ORALARG" local_name_id="21" end="22297" >Oral Arg</NAME>

<LEGAL_ROLE start="22384" end="22393" id="8050_325" >plaintiff</LEGAL_ROLE>

<PERSON start="22440" end="22451" id="8050_326" >Halliburton</PERSON>

<LEGAL_ROLE start="22455" end="22464" id="8050_327" >plaintiff</LEGAL_ROLE>

<LEGAL_ROLE start="22558" end="22567" id="8050_328" >defendant</LEGAL_ROLE>

<NAME id="8050_329" start="22569" all_names="TR" local_name_id="20" end="22571" >Tr</NAME>

<NAME id="8050_330" start="22576" all_names="ORALARG" local_name_id="21" end="22584" >Oral Arg</NAME>

<RELATION gram_type="apposition" relation_type="equivalence" standard_case="8050_25" id="8050_48" standard_case_string="563 U. S. ___" X_vs_Y_string="Matrixx Initiatives, Inc. v. Siracusano" X_vs_Y="8050_27" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_29" party1_string="Matrixx Initiatives, Inc." theme_string="Matrixx Initiatives, Inc. v. Siracusano" id="8050_46" theme="8050_27" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_30" theme_string="Matrixx Initiatives, Inc. v. Siracusano" id="8050_47" theme="8050_27" party2_string="Siracusano" ></RELATION>

<RELATION gram_type="apposition" relation_type="equivalence" standard_case="8050_26" id="8050_51" standard_case_string="485 U. S. 224" X_vs_Y_string="Basic Inc. v. Levinson" X_vs_Y="8050_28" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_31" party1_string="Basic Inc." theme_string="Basic Inc. v. Levinson" id="8050_49" theme="8050_28" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_32" theme_string="Basic Inc. v. Levinson" id="8050_50" theme="8050_28" party2_string="Levinson" ></RELATION>

<RELATION gram_type="apposition" relation_type="equivalence" standard_case="8050_56" id="8050_70" standard_case_string="544 U. S. 336, 341-342" X_vs_Y_string="Dura Pharmaceuticals, Inc. v. Broudo" X_vs_Y="8050_57" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_58" party1_string="Dura Pharmaceuticals, Inc." theme_string="Dura Pharmaceuticals, Inc. v. Broudo" id="8050_68" theme="8050_57" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_59" theme_string="Dura Pharmaceuticals, Inc. v. Broudo" id="8050_69" theme="8050_57" party2_string="Broudo" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_92" party1_string="ARCHDIOCESE OF MILWAUKEE SUPPORTING FUND, INC.," theme_string="ARCHDIOCESE OF MILWAUKEE SUPPORTING FUND, INC.,PETITIONER v. HALLIBURTON CO. et al" id="8050_98" theme="8050_91" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_93" theme_string="ARCHDIOCESE OF MILWAUKEE SUPPORTING FUND, INC.,PETITIONER v. HALLIBURTON CO. et al" id="8050_99" theme="8050_91" party2_string="HALLIBURTON CO. et al" ></RELATION>

<RELATION gram_type="pre_nom" relation_type="asymmetric" profession_string="Chief Justice" theme_string="Roberts" id="8050_104" theme="8050_102" profession="8050_101" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_139" party1_string="Oscar Private Equity Invs." theme_string="Oscar Private Equity Invs. v. Allegiance Telecom" id="8050_159" theme="8050_137" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_140" theme_string="Oscar Private Equity Invs. v. Allegiance Telecom" id="8050_160" theme="8050_137" party2_string="Allegiance Telecom" ></RELATION>

<RELATION gram_type="apposition" relation_type="equivalence" standard_case="8050_136" id="8050_163" standard_case_string="544 U. S. 336, 342 (2005)" X_vs_Y_string="Dura Pharmaceuticals, Inc. v. Broudo" X_vs_Y="8050_138" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_141" party1_string="Dura Pharmaceuticals, Inc." theme_string="Dura Pharmaceuticals, Inc. v. Broudo" id="8050_161" theme="8050_138" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_142" theme_string="Dura Pharmaceuticals, Inc. v. Broudo" id="8050_162" theme="8050_138" party2_string="Broudo" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" theme_string="544 U. S. 336, 342 (2005)" id="8050_164" at_date_string="2005" theme="8050_136" at_date="8050_144" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" theme_string="562 U. S. ___ (2011)" id="8050_195" at_date_string="2011" theme="8050_175" at_date="8050_183" ></RELATION>

<RELATION gram_type="apposition" relation_type="equivalence" standard_case="8050_177" case_citation_other="8050_188" id="8050_196" standard_case_string="544 F. 3d 474, 483" case_citation_other_string="In re Salomon Analyst Metromedia Litigation" ></RELATION>

<RELATION gram_type="apposition" relation_type="equivalence" standard_case="8050_178" id="8050_199" standard_case_string="618 F. 3d 679, 687" X_vs_Y_string="Schleicher v. Wendt" X_vs_Y="8050_180" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_181" party1_string="Schleicher" theme_string="Schleicher v. Wendt" id="8050_197" theme="8050_180" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_182" theme_string="Schleicher v. Wendt" id="8050_198" theme="8050_180" party2_string="Wendt" ></RELATION>

<RELATION gram_type="apposition" relation_type="equivalence" standard_case="8050_202" id="8050_223" standard_case_string="563 U. S. ___" X_vs_Y_string="Matrixx Initiatives, Inc. v. Siracusano" X_vs_Y="8050_204" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_206" party1_string="Matrixx Initiatives, Inc." theme_string="Matrixx Initiatives, Inc. v. Siracusano" id="8050_221" theme="8050_204" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_207" theme_string="Matrixx Initiatives, Inc. v. Siracusano" id="8050_222" theme="8050_204" party2_string="Siracusano" ></RELATION>

<RELATION gram_type="apposition" relation_type="equivalence" standard_case="8050_203" id="8050_226" standard_case_string="552 U. S. 148, 157 (2008)" X_vs_Y_string="Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc" X_vs_Y="8050_205" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_208" party1_string="Stoneridge Investment Partners, LLC" theme_string="Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc" id="8050_224" theme="8050_205" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_209" theme_string="Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc" id="8050_225" theme="8050_205" party2_string="Scientific-Atlanta, Inc" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" theme_string="552 U. S. 148, 157 (2008)" id="8050_227" at_date_string="2008" theme="8050_203" at_date="8050_211" ></RELATION>

<RELATION gram_type="apposition" relation_type="equivalence" standard_case="8050_229" id="8050_244" standard_case_string="485 U. S. 224, 243 (1988)" X_vs_Y_string="Basic Inc. v. Levinson" X_vs_Y="8050_230" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party1="8050_231" party1_string="Basic Inc." theme_string="Basic Inc. v. Levinson" id="8050_242" theme="8050_230" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" party2="8050_232" theme_string="Basic Inc. v. Levinson" id="8050_243" theme="8050_230" party2_string="Levinson" ></RELATION>

<RELATION gram_type="infix" relation_type="asymmetric" theme_string="485 U. S. 224, 243 (1988)" id="8050_245" at_date_string="1988" theme="8050_229" at_date="8050_233" ></RELATION>

